Phase 2 Transition Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2Phase 3
Multicenter Clinical Trial of ST-02 for Ablation of Upper Tract Urothelial Carcinoma
Urothelial Carcinoma of the Renal Pelvis and UreterTransitional Cell Cancer of the Renal Pelvis and Ureter
University of British Columbia70 enrolled4 locationsNCT06124976
Recruiting
Phase 2
Chemoablation for Low-Grade Bladder Cancer
Bladder (Urothelial, Transitional Cell) Cancer
Ekaterina Laukhtina47 enrolled1 locationNCT07019220
Recruiting
Phase 2
PD1 Inhibitors Combined With Clostridium Butyricum for Urothelial Carcinoma
Bladder (Urothelial, Transitional Cell) Cancer
The First Affiliated Hospital with Nanjing Medical University60 enrolled1 locationNCT06696742
Recruiting
Phase 2Phase 3
Dapaglifozin to Avoid Acute Kindey Injury (AKI) to Chronic Kidney Disease (CKD) Transition: DAKI-CKD Study
BiomarkersAKI - Acute Kidney InjuryCKD+1 more
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran100 enrolled1 locationNCT05713851